Details for New Drug Application (NDA): 080751
✉ Email this page to a colleague
NDA 080751 describes INFLAMASE MILD, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the INFLAMASE MILD profile page.
The generic ingredient in INFLAMASE MILD is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
The generic ingredient in INFLAMASE MILD is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
Summary for 080751
| Tradename: | INFLAMASE MILD |
| Applicant: | Novartis |
| Ingredient: | prednisolone sodium phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.11% PHOSPHATE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.9% PHOSPHATE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
